Mutations of p53 in thyroid carcinoma with an insular component

被引:45
|
作者
Takeuchi, Y [1 ]
Daa, T
Kashima, K
Yokoyama, S
Nakayama, I
Noguchi, S
机构
[1] Oita Med Univ, Dept Pathol, Hasama, Oita 8795593, Japan
[2] Noguchi Thyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
D O I
10.1089/thy.1999.9.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid carcinoma with an insular component (TCIC) is considered noteworthy in view of its peculiar histopathological features and clinicopathological behavior. The purpose of the present study was to clarify the rate of mutation in the p53 gene in TCIC as compared with rates in papillary and follicular carcinomas of the thyroid. Formalin-fixed and paraffin-embedded blocks of tissue from 46 cases of TCIC were analyzed. DNA was extracted from tissues and exons 5 through 8 of the p53 gene were amphfied by the polymerase chain reaction. Mutations were detected by analysis of single-strand conformation polymorphism. Of the 46 cases of TCIC, 6 had a mutation in exon 5, 2 in exon 7, and 5 in exon 8, while 1 case had mutations in all exons examined. The mutation rate of the p53 gene in TCIC was 38%. Immunostaining revealed overexpression of p53 in nuclei that were mainly in areas of the insular component rather than in surrounding areas of well-differentiated carcinoma. The frequency of positive immunostaining in TCIC was 53%. Considering that TCIC is intermediate between papillary plus follicular carcinoma and anaplastic carcinoma in terms of survival and the rate of mutation of the p53 gene, we can speculate that mutation in the p53 gene might be associated with the insular component and might play an important role in the clinicopathological behavior of thyroid carcinoma.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [41] p53 mutations in cancer
    Muller, Patricia A. J.
    Vousden, Karen H.
    NATURE CELL BIOLOGY, 2013, 15 (01) : 2 - 8
  • [42] p53 mutations in chondrosarcoma
    Terek, RM
    Healey, JH
    Garin-Chesa, P
    Mak, S
    Huvos, A
    Albino, AP
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (01) : 51 - 56
  • [43] p53 mutations in cancer
    Patricia A. J. Muller
    Karen H. Vousden
    Nature Cell Biology, 2013, 15 : 2 - 8
  • [44] p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma
    MatiasGuiu, X
    Villanueva, A
    Cuatrecasas, M
    Capella, G
    DeLeiva, A
    Prat, J
    PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (12) : 1242 - 1249
  • [45] Insular and anaplastic carcinoma of the thyroid - A 45-year comparative study at a single institution and a review of the significance of p53 and p21
    Lam, KY
    Lo, CY
    Chan, KW
    Wan, KY
    ANNALS OF SURGERY, 2000, 231 (03) : 329 - 338
  • [46] Carcinoma of the thyroid with insular component: concerning 2 cases
    El M'Ghari, G.
    Khanouach, H.
    Chadli, A.
    El Ghomari, H.
    Farouqi, A.
    DIABETES & METABOLISM, 2007, 33 : S139 - S139
  • [47] Immunohistochemical detection of p53 and p53 gene mutations in meningioma
    Hirato, J
    Sakurai, S
    Nakazato, Y
    BRAIN PATHOLOGY, 1997, 7 (04) : 1193 - 1193
  • [48] Low frequency of p53 mutations in human thyroid tumors; p53 and Ras mutation in two out of fifty-six thyroid tumours
    Salvatore, D
    Celetti, A
    Fabien, N
    Paulin, C
    Martelli, ML
    Battaglia, C
    Califano, D
    Monaco, C
    Viglietto, G
    Santoro, M
    Fusco, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (02) : 177 - 183
  • [49] p53 Expression and mutations in oral squamous cell carcinoma.
    VanHeerden, WFP
    VanRensburg, EJ
    Engelbrecht, S
    Raubenheimer, EJ
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 1208 - 1208
  • [50] P53 MUTATIONS AND HISTOLOGICAL TYPE OF INVASIVE BREAST-CARCINOMA
    MARCHETTI, A
    BUTTITTA, F
    PELLEGRINI, S
    CAMPANI, D
    DIELLA, F
    CECCHETTI, D
    CALLAHAN, R
    BISTOCCHI, M
    CANCER RESEARCH, 1993, 53 (19) : 4665 - 4669